Medtronic received information via literature regarding early and late outcomes of aortic valve replacement using bioprosthetic versus mechanical valve in elderly patients: a propensity analysis.All data were collected from a single center between (b)(6) 2014.The study population included 277 patients (predominantly female, mean age 80 years), 24 of which were implanted with medtronic ats mechanical valves and 36 were implanted with medtronic mosaic tissue valves (serial numbers not provided).Among all patients 14 deaths occurred.Multiple manufacturers were noted in the literature; based on the available information, none of the deaths were attributed to medtronic product.Among all patients adverse events included: cardiac arhythmias (atrioventricular block, ventricular fibrillation), re-operation for bleeding, stroke, infection, congestive heart failure, myocardial infarction, angina, minor paravalvular leak, thromboembolism.Based on the available information, these adverse events may have been attributed to medtronic product.
|